Clinical Trials Search
Clinical Trial 17981
Cancer Type: Genitourinary
Interventions:Abiraterone acetate; Zytiga (Abiraterone acetate)
Study Type: Treatment
Phase of Study: Pilot
- Jingsong Zhang
A Pilot Study of Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
The purpose of this study is to find out if an on and off schedule of taking abiraterone would prolong the participant's cancer's response to this drug and maintain their functionality to perform their daily activities.
Describe the percentage of abiraterone responsive (defined as 50% decline of PSA) blacks and non-blacks who remain to be responsive to abiraterone after completing 2 adaptive treatment cycles.